Footnotes

• Competing interests MG has received consulting fee from Medtronic for conduct and design of SWIFT PRIME trial. ESCAPE trial for partly funded by Medtronic through a grant to University of Calgary. MG has developed technologies related to improving systems of stroke diagnosis that has been subsequently licensed to GE Healthcare.

• Provenance and peer review Not commissioned; internally peer reviewed.